1. An introduction to multiplicity issues in clinical trials: The what, why, when and how;Li;Int J Epidemiol,2017
2. Center for Drug Evaluation and Research. Multiple Endpoints in Clinical Trials Guidance for Industry. Center for Drug Evaluation and Research; 2017. Available from: http://www.fda.gov/downloads/ drugs/guidancecomplianceregulatoryinformation/guidances/ ucm536750.pdf. [Last retrieved on 2018 Dec 12].
3. Draft Guideline on Multiplicity Issues in Clinical Trials (EMA/ CHMP/44762/2017). Committee for Human Medicinal Products; 2016. Available from: http://www.ema.europa.eu/documents/scientific-guideline/draft-guideline-multiplicity-issues-clinical-trials_en.pdf. [Last retrieved on 2018 Dec 12].
4. Editorial: Multiplicity issues in clinical trials;Dmitrienko;Stat Med,2017
5. Extended thromboprophylaxis with betrixaban in acutely ill medical patients;Cohen;N Engl J Med,2016